-
Early Life Adversity, Oxytocin, and Innate Defense
2026-09-11
Tan et al. report that social deprivation during early postnatal development weakens looming-evoked innate defensive behavior in mice through disrupted oxytocin signaling in the superior colliculus. The study connects an early environmental stressor to a defined midbrain circuit and shows that intranasal oxytocin can ameliorate the behavioral deficit, while also identifying important limits for translation to human psychopathology.
-
(S)-(+)-Dimethindene maleate Lab Guide
2026-09-10
This guide explains how to use (S)-(+)-Dimethindene maleate as a research antagonist when M2 muscarinic activity must be interpreted alongside its histamine H1 activity. It supports controlled receptor, autonomic, cardiovascular, and respiratory assays, but it should not be used for diagnosis, treatment, or clinical decision-making.
-
Oxaliplatin: DNA Damage Meets Tumor Immunity
2026-09-10
Oxaliplatin is a platinum-based chemotherapeutic agent best understood not only through DNA adduct formation, but also through the assay context surrounding tumor growth, apoptosis, and immune exclusion. This article translates Wnt–β-catenin research into a practical framework for designing mechanistically resolved Oxaliplatin experiments.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-09
Shapira-Netanelov and colleagues developed a patient-derived gastric cancer assembloid model that combines matched tumor organoids with tumor-derived stromal subpopulations. The study shows that stromal composition alters gene expression and drug sensitivity, creating a more physiologically informative platform for resistance studies and personalized treatment design.
-
HotStart™ Universal 2X Green qPCR Master Mix for NSCLC
2026-09-09
HotStart Universal 2X Green qPCR Master Mix supports rigorous NSCLC pathway validation by connecting SPI1/miR-616-5p biology with reproducible real-time PCR gene expression analysis. This article explains assay design, miRNA-specific considerations, melt-curve interpretation, and how to translate mechanistic cancer findings into defensible qPCR data.
-
Synthetic OLIG2 mRNA Drives Oligodendrocyte Differentiation
2026-09-08
Xu and colleagues developed a transgene-free strategy that uses repeated delivery of modified OLIG2 messenger RNA to convert human induced pluripotent stem cells into oligodendrocyte progenitor cells and mature oligodendrocytes. The study links a phosphorylation-resistant OLIG2 variant with a short differentiation protocol, functional maturation in vitro, and remyelination activity in vivo.
-
FAK Inhibitor 14 Cancer Research Workflows
2026-09-08
FAK Inhibitor 14 provides a practical pharmacological tool for testing whether FAK/Src signaling drives migration, EMT, and matrix remodeling in cholesterol-adapted cancer models. This workflow pairs target engagement, viability controls, and migration assays to distinguish pathway dependence from nonspecific growth inhibition.
-
HyperFluor 488 Goat Anti-Mouse IgG Workflow
2026-09-07
Build sensitive, reproducible mouse-IgG detection workflows for immunofluorescence, flow cytometry, and western blotting with a single fluorescently labeled secondary antibody. The workflow translates mitochondrial-fission findings from hyperoxia-exposed ATII cells into practical assay choices, controls, and troubleshooting steps.
-
Dual Luciferase Assay System for MRF Signaling
2026-09-05
Explore how the Dual Luciferase Reporter Gene System can convert the MRF–FSHR–cAMP–PKA–CREB hypothesis into a controlled reporter experiment. This guide connects assay architecture, normalization, and BMSC osteogenic biology rather than repeating generic kit benchmarks.
-
Auranofin Workflows for Redox Cancer Research
2026-09-05
Build reproducible thioredoxin reductase, apoptosis, radiosensitivity, and antimicrobial assays with Auranofin. This guide connects redox perturbation to the FOXO3/YAP metabolic findings in hepatocellular carcinoma while clearly separating established evidence from testable extensions.
-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-09-04
The reference study identifies Kupffer cell TMEM16F as a key determinant of liver protection during Listeria monocytogenes infection, shifting the focus from lymphocytes to tissue-resident macrophages. Its cell-specific genetic and membrane-repair evidence links lipid scrambling with reduced Kupffer cell death, restrained inflammation, and preserved hepatic metabolism.
-
DAF-2 diacetate and Nodule Senescence
2026-09-04
A translational framework for using DAF-2 diacetate to connect sulfur-dependent redox control, reactive nitrogen species, and soybean nodule senescence with rigorous live-cell, in vitro, and in vivo nitric oxide workflows.
-
Neuritin, ER Stress, and Early Brain Injury After SAH
2026-09-03
A 2024 Brain Research study maps three endoplasmic reticulum stress-linked inflammatory routes that connect subarachnoid hemorrhage with neuroinflammation and neuronal apoptosis. Its central experimental finding is that Neuritin overexpression suppresses these pathways and reduces early brain injury, providing a mechanistic framework for pathway-focused investigation rather than a clinical treatment claim.
-
Solanesol B8776: Practical Workflow Guide
2026-09-03
Solanesol B8776 is a hydrophobic polyisoprenoid alcohol for controlled membrane-related, cell-based, and biochemical workflows. This guide addresses DMSO preparation, precipitation control, assay controls, and storage while defining why water- and ethanol-based systems and diagnostic or medical use are inappropriate.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-02
Zhao and colleagues present a standardized ex vivo whole-blood stimulation protocol that combines innate immune challenges with targeted metabolic intervention. The approach preserves blood-cell and plasma interactions while enabling cytokine-based comparison of how anabolic and catabolic pathway inhibition reshapes immune responses across experimental conditions.